Godavari Drugs Ltd

₹ 101 0.52%

25 Apr 4:01 p.m.

About

Incorporated in 1987, Godavari Drugs Ltd manufactures and sale of Active Pharmaceutical Ingredients and their intermediates^[1]

Key Points

Business Overview:^[1]
Company is in the business of Manufacturing APIs, drug intermediaries, and fine chemicals and caters to the global Life Science Industry. It has an active Loan License and Contract Manufacturing tie-ups with multinational companies for APIs and drug intermediates

Website BSE

Market Cap ₹ 76.0 Cr.
Current Price ₹ 101
High / Low ₹ 114 / 76.2
Stock P/E 18.7
Book Value ₹ 46.6
Dividend Yield 0.00 %
ROCE 14.2 %
ROE 11.4 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company's median sales growth is 23.8% of last 10 years

Cons

Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	33.10	32.96	44.40	38.67	33.76	44.28	42.55	40.55	39.16	37.37	35.42	39.54	43.11
	30.53	30.39	41.31	35.76	31.17	41.58	40.15	37.98	36.89	34.69	33.17	36.47	39.59
Operating Profit	2.57	2.57	3.09	2.91	2.59	2.70	2.40	2.57	2.27	2.68	2.25	3.07	3.52
OPM %	7.76%	7.80%	6.96%	7.53%	7.67%	6.10%	5.64%	6.34%	5.80%	7.17%	6.35%	7.76%	8.17%
	0.08	0.11	0.02	0.09	0.05	0.12	0.07	0.13	0.30	0.39	0.45	0.00	-0.01
Interest	0.82	0.81	0.71	0.79	0.73	0.62	0.74	1.06	1.10	1.03	1.11	1.30	1.27
Depreciation	0.29	0.37	0.42	0.43	0.43	0.42	0.46	0.47	0.51	0.50	0.47	0.49	0.50
Profit before tax	1.54	1.50	1.98	1.78	1.48	1.78	1.27	1.17	0.96	1.54	1.12	1.28	1.74
Tax %	35.06%	14.00%	28.28%	31.46%	9.46%	29.21%	26.77%	26.50%	30.21%	13.64%	27.68%	32.81%	29.89%
	1.00	1.29	1.42	1.22	1.33	1.27	0.92	0.86	0.67	1.33	0.81	0.86	1.22
EPS in Rs	1.33	1.71	1.89	1.62	1.77	1.69	1.22	1.14	0.89	1.77	1.08	1.14	1.62
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
	4	8	9	55	71	76	64	84	96	123	161	160	155
	4	6	8	49	67	70	60	78	90	113	150	150	144
Operating Profit	-1	2	2	6	4	5	4	5	6	10	11	10	12
OPM %	-15%	21%	20%	11%	6%	7%	6%	7%	6%	8%	7%	6%	7%
	0	0	0	0	0	1	1	0	0	0	0	1	1
Interest	0	0	0	1	2	3	2	3	3	3	3	4	5
Depreciation	1	1	1	1	1	1	1	1	1	1	2	2	2
Profit before tax	-2	1	1	5	2	3	1	2	2	6	7	5	6
Tax %	0%	33%	-121%	23%	38%	33%	37%	31%	13%	28%	25%	23%
	-2	0	2	4	1	2	1	1	2	4	5	4	4
EPS in Rs	-2.12	0.64	2.06	4.85	1.79	2.40	1.10	1.61	2.66	5.48	6.97	5.03	5.61
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	36%
5 Years:	20%
3 Years:	19%
TTM:	-7%

Compounded Profit Growth
10 Years:	22%
5 Years:	34%
3 Years:	22%
TTM:	9%

Stock Price CAGR
10 Years:	25%
5 Years:	34%
3 Years:	18%
1 Year:	29%

Return on Equity
10 Years:	14%
5 Years:	14%
3 Years:	16%
Last Year:	11%

Balance Sheet

Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Sep 2023
Equity Capital	8	8	8	8	8	8	8	8	8	8	8	8	8
Reserves	-0	0	2	6	7	9	10	11	13	17	22	26	28
	2	2	2	8	16	16	19	22	28	30	23	36	34
	6	5	3	13	21	24	27	33	36	36	49	52	58
Total Liabilities	15	15	15	35	51	56	63	74	84	91	101	121	127
	8	7	8	7	9	13	15	15	14	22	26	25	24
CWIP	0	0	0	0	1	0	1	2	9	1	0	9	13
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
	7	7	7	27	41	43	47	57	61	68	75	87	90
Total Assets	15	15	15	35	51	56	63	74	84	91	101	121	127

Cash Flows

Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
	0	1	2	-6	-5	5	4	4	6	1	11	13
	-1	-1	-2	-0	-2	-3	-3	-2	-7	-1	-5	-9
	1	1	0	6	7	-2	-0	-1	0	0	-6	-4
Net Cash Flow	-0	0	-0	0	0	0	1	-0	-0	0	1	1

Ratios

Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Debtor Days	40	32	20	87	126	117	152	148	137	134	126	132
Inventory Days	1,253	1,484	973	84	67	70	100	93	84	55	28	57
Days Payable	554	284	179	79	108	124	171	171	144	112	121	132
Cash Conversion Cycle	739	1,231	814	92	85	63	81	70	78	78	33	58
Working Capital Days	177	147	120	95	104	95	112	95	88	86	52	73
ROCE %	-15%	9%	8%	32%	16%	17%	11%	12%	12%	18%	18%	14%

Shareholding Pattern

Numbers in percentages

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	56.13%	56.13%	56.13%	56.36%	56.92%	56.92%	53.12%	53.12%	53.16%	53.16%	53.16%	53.16%
	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%
	43.38%	43.38%	43.38%	43.15%	42.58%	42.58%	46.37%	46.39%	46.34%	46.33%	46.35%	46.34%
No. of Shareholders	4,567	5,394	5,750	6,034	6,232	5,968	6,651	6,555	6,561	7,019	6,894	7,005

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	49.91%	54.00%	54.00%	55.86%	55.86%	56.36%	53.12%	53.16%
	0.00%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%
	50.09%	45.51%	45.51%	43.65%	43.65%	43.15%	46.39%	46.34%
No. of Shareholders	4,285	4,083	3,980	3,928	4,136	6,034	6,555	7,005

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Godavari Drugs Ltd

Godavari Drugs Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings